Divi's Laboratories

{{Short description|Indian pharmaceutical company}}

{{Use Indian English|date=September 2020}}

{{Use dmy dates|date=September 2020}}

{{Third-party|date=March 2023}}

{{Infobox company

| name = Divi's Laboratories Limited

| logo = File:Divi's Laboratories Logo.svg

| logo_size = 250px

| logo_alt = Divi's Laboratories' logo

| logo_caption = Divi's Laboratories' logo

| former_name = Divi's Research Centre

| type = Public

| traded_as = {{ubl|{{BSE|532488}}|{{NSE|DIVISLAB}}}}

| ISIN = INE361B01024

| industry = Pharmaceuticals

| services = Custom synthesis

| revenue = {{Increase}} {{INRConvert|9712|c}}

| revenue_year = 2025

| operating_income = {{Increase}} {{INRConvert|2916|c}}

| income_year = 2025

| net_income = {{Increase}} {{INRConvert|2194|c}}

| net_income_year = 2025

| assets = {{Increase}} {{INRConvert|16932|c}}

| assets_year = 2025

| equity = {{Increase}} {{INRConvert|14969|c}}

| equity_year = 2025

| founded = {{Start date and age|1990|10|12|df=yes|p=yes}}

| hq_location = Divi Towers, Cyber Hills, Gachibowli

| hq_location_city = Hyderabad, Telangana

| hq_location_country = India

| key_people = {{ubl|Murali Krishna Prasad Divi (MD)|Satchandra Kiran Divi (CEO)}}

| products = Active Pharmaceutical Ingredients
Nutraceuticals

| owner = {{ubl|Divi Satchandra Kiran (20.34%)|Nilima Motaparti (20.34%)|Divi Swarna Latha (5.27%)|Divis Biotech Private Limited (3.01%)|Murali Krishna Prasad Divi (2.85%)}}

| num_employees = 13,884

| num_employees_year = 2020

| subsid = {{ubl|Divis Laboratories (USA) Inc|Divi’s Laboratories Europe AG|Divi’s Nutraceuticals}}

| website = {{URL|divislabs.com}}

| footnotes = Financials {{as of|2025|03|31|lc=y|df=yes}}.{{cite web |title=Statement of Audited Financial Results, Standalone and Consolidated, for the quarter and year ended March 31, 2025 |url=https://www.divislabs.com/wp-content/uploads/2025/05/Outcome-of-Board-Meeting-held-on-May-17-2025.pdf |publisher=Divi's Laboratories Limited |access-date=28 May 2025}}

}}

Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad.{{Cite web|title=Company Profile-DIVIS LAB|url=https://stock-financials.valuestocks.in/en/divis-lab-company-profile|access-date=2020-09-15|website=Dynamic Levels|language=en-US|archive-date=18 October 2020|archive-url=https://web.archive.org/web/20201018134310/https://stock-financials.valuestocks.in/en/divis-lab-company-profile|url-status=live}}{{Cite web|title=Company Profile for Divi's Laboratories Ltd|url=https://in.reuters.com/finance/stocks/company-profile/DIVI.BO|access-date=2020-09-15|work=Reuters|archive-date=18 October 2017|archive-url=https://web.archive.org/web/20171018154537/http://in.reuters.com/finance/stocks/company-profile/DIVI.BO|url-status=dead}}{{Cite web|title=Divi's Laboratories Ltd Company profile|url=https://www.bloomberg.com/profile/company/DIVI:IN|url-status=live|archive-url=https://web.archive.org/web/20201018134310/https://www.bloomberg.com/profile/company/DIVI:IN|archive-date=18 October 2020|access-date=2020-09-15|publisher=Bloomberg L.P.}}{{Cite web|title=DIVI'S LABORATORIES LIMITED - Company, directors and contact details {{!}} Zauba Corp|url=https://www.zaubacorp.com/company/DIVI-S-LABORATORIES-LIMITED/L24110TG1990PLC011854|access-date=2020-09-15|website=www.zaubacorp.com|archive-date=18 October 2020|archive-url=https://web.archive.org/web/20201018134313/https://www.zaubacorp.com/company/DIVI-S-LABORATORIES-LIMITED/L24110TG1990PLC011854|url-status=live}} The company manufactures and custom synthesizes generic APIs, intermediates.{{Cite web|title=Top API Manufacturing Company In Hyderabad, India & World {{!}} DivisLabs|url=https://www.divislabs.com/api-manufacturing-company/|access-date=2020-09-15|website=Divis Laboratories World’s largest API manufacturing facility|language=en-US|archive-date=12 August 2020|archive-url=https://web.archive.org/web/20200812025954/https://www.divislabs.com/api-manufacturing-company/|url-status=live}}{{Cite web|last=Bradstreet|first=Dun|title=Divi's Laboratories company profile|url=https://www.dnb.com/business-directory/company-profiles.divis_laboratories_limited.344527b03327427e0ce523821ee82d40.html|access-date=|website=dnb.com|archive-date=18 October 2020|archive-url=https://web.archive.org/web/20201018134332/https://www.dnb.com/business-directory/company-profiles.divis_laboratories_limited.344527b03327427e0ce523821ee82d40.html|url-status=live}} The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals.{{Cite web |last=Divis Nutraceuticals |date=2021-09-14 |title=Press Release: Divi's Nutraceuticals launches CaroNat for natural food and beverage coloration |url=https://divisnutraceuticals.com/press-release-divis-nutraceuticals-launches-caronat-for-natural-food-and-beverage-coloration/ |access-date=2022-07-27 |website=Divi's Nutraceuticals |language=en-US}} Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.{{cite news |title=Top Pharmaceuticals & Drugs Stocks in India by Market Capitalisation |url=https://www.moneycontrol.com/stocks/marketinfo/marketcap/bse/pharmaceuticals-drugs.html |access-date=15 February 2023 |work=www.moneycontrol.com |language=en |archive-date=13 January 2023 |archive-url=https://web.archive.org/web/20230113195129/https://www.moneycontrol.com/stocks/marketinfo/marketcap/bse/pharmaceuticals-drugs.html |url-status=live }}

History

The company initially started developing commercial processes for the manufacturing of APIs and intermediates. Divi's Research Centre changed its name to Divi's Laboratories Limited in 1994 to signal its intent to enter the API and intermediates manufacturing industry.{{Cite web|title=Divis Laboratories > Company History > Pharmaceuticals > Company History of Divis Laboratories - BSE: 532488, NSE: DIVISLAB|url=https://www.moneycontrol.com/company-facts/divislaboratories/history/dl03|access-date=2020-09-17|website=moneycontrol.com|language=en|archive-date=6 June 2020|archive-url=https://web.archive.org/web/20200606223407/https://www.moneycontrol.com/company-facts/divislaboratories/history/DL03|url-status=live}} Following this, the company established its first Manufacturing facility in 1995 at Choutuppal, Telangana. In 2002, the company's second manufacturing facility commenced operations at Chippada near Visakhapatnam.

The company went public with its initial public offering (IPO) on 17 February 2003.{{Cite web|date=2003-02-11|title=Divis Labs Fixes Rs 130 Per Share As Floor Price For IPO|url=https://www.financialexpress.com/archive/divis-labs-fixes-rs-130-per-share-as-floor-price-for-ipo/72906/|access-date=2020-09-18|website=The Financial Express|language=en-US|archive-date=17 March 2018|archive-url=https://web.archive.org/web/20180317125855/http://www.financialexpress.com/archive/divis-labs-fixes-rs-130-per-share-as-floor-price-for-ipo/72906/|url-status=live}} In 2010, the company established a research centre in Hyderabad.

Facilities

The company has three manufacturing facilities and three R&D centres across India:{{Cite web|last=Laboratories|first=Divi's|title=Annual Report|url=https://www.divislabs.com/wp-content/uploads/2020/09/30th-Divi-Annual-Report.pdf|url-status=live|archive-url=https://web.archive.org/web/20201018134305/https://www.divislabs.com/wp-content/uploads/2020/09/30th-Divi-Annual-Report.pdf|archive-date=18 October 2020|access-date=|website=divislabs.com}}

= Manufacturing =

References